Literature DB >> 21295682

Childhood cancer and developmental biology a crucial partnership.

Sara Federico1, Rachel Brennan, Michael A Dyer.   

Abstract

For many years, there were relatively few research efforts that bridged the fields of developmental biology and cancer genetics. However, in the past decade, we have witnessed a dramatic shift and now these two fields are intertwined. Part of the impetus for this transition came from the discovery that regulatory pathways that were previously thought to be uniquely important for developmental processes were also perturbed in cancer. In addition, the conceptual framework for understanding how cells self-renew or undergo unidirectional changes in competence during development has proven to be very useful in cancer biology as researchers explore tumor initiation and progression. Finally, a deeper understanding of the process of terminal differentiation and how that relates to cellular plasticity may have important implications for both cancer biology and developmental biology. Here we highlight some of the important connections between developmental neurobiology and cancer biology in retinoblastoma. By bridging these fields, important advances have been made in modeling retinoblastoma in mice, elucidating the cell-of-origin for retinoblastoma and identifying novel therapeutic approaches.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21295682      PMCID: PMC3551576          DOI: 10.1016/B978-0-12-380916-2.00001-2

Source DB:  PubMed          Journal:  Curr Top Dev Biol        ISSN: 0070-2153            Impact factor:   4.897


  39 in total

1.  Rapid growth of retinoblastoma in a premature twin.

Authors:  David H Abramson; Amy C Schefler; Katherine L Beaverson; Indira S Rollins; Michael S Ruddat; Christopher J Kelly
Journal:  Arch Ophthalmol       Date:  2002-09

Review 2.  The Hedgehog response network: sensors, switches, and routers.

Authors:  Lawrence Lum; Philip A Beachy
Journal:  Science       Date:  2004-06-18       Impact factor: 47.728

3.  Characterization of a new continuous cell line derived from a human retinoblastoma.

Authors:  R C McFall; T W Sery; M Makadon
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

Review 4.  Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer.

Authors:  D DiCiommo; B L Gallie; R Bremner
Journal:  Semin Cancer Biol       Date:  2000-08       Impact factor: 15.707

5.  Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing Program.

Authors:  Peter J Houghton; Christopher L Morton; Richard Gorlick; E Anders Kolb; Stephen T Keir; C Patrick Reynolds; Min H Kang; John M Maris; Jianrong Wu; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2010-07-01       Impact factor: 3.167

6.  Initial testing of topotecan by the pediatric preclinical testing program.

Authors:  Hernan Carol; Peter J Houghton; Christopher L Morton; E Anders Kolb; Richard Gorlick; C Patrick Reynolds; Min H Kang; John M Maris; Stephen T Keir; Amy Watkins; Malcolm A Smith; Richard B Lock
Journal:  Pediatr Blood Cancer       Date:  2010-05       Impact factor: 3.167

7.  Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma.

Authors:  Danian Chen; Izhar Livne-bar; Jackie L Vanderluit; Ruth S Slack; Mahima Agochiya; Rod Bremner
Journal:  Cancer Cell       Date:  2004-06       Impact factor: 31.743

Review 8.  Diagnosis and management of retinoblastoma.

Authors:  Carol L Shields; Jerry A Shields
Journal:  Cancer Control       Date:  2004 Sep-Oct       Impact factor: 3.302

9.  Cell type-specific effects of Rb deletion in the murine retina.

Authors:  David MacPherson; Julien Sage; Teresa Kim; Dennis Ho; Margaret E McLaughlin; Tyler Jacks
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

Review 10.  Mouse models of childhood cancer of the nervous system.

Authors:  M A Dyer
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

View more
  9 in total

1.  CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.

Authors:  Mike R Russell; Annalise Penikis; Derek A Oldridge; Juan R Alvarez-Dominguez; Lee McDaniel; Maura Diamond; Olivia Padovan; Pichai Raman; Yimei Li; Jun S Wei; Shile Zhang; Janahan Gnanchandran; Robert Seeger; Shahab Asgharzadeh; Javed Khan; Sharon J Diskin; John M Maris; Kristina A Cole
Journal:  Cancer Res       Date:  2015-06-22       Impact factor: 12.701

Review 2.  Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.

Authors:  Eleanor M Pritchard; Michael A Dyer; R Kiplin Guy
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

Review 3.  The prenatal origins of cancer.

Authors:  Glenn M Marshall; Daniel R Carter; Belamy B Cheung; Tao Liu; Marion K Mateos; Justin G Meyerowitz; William A Weiss
Journal:  Nat Rev Cancer       Date:  2014-03-06       Impact factor: 60.716

4.  Isotope tracing reveals glycolysis and oxidative metabolism in childhood tumors of multiple histologies.

Authors:  Kendra Johnston; Panayotis Pachnis; Alpaslan Tasdogan; Brandon Faubert; Lauren G Zacharias; Hieu Sy Vu; Laurie Rodgers-Augustyniak; Allison Johnson; Fang Huang; Sean Ricciardo; Zhiyu Zhao; Thomas P Mathews; Tanya Watt; Patrick Leavey; Ralph J DeBerardinis
Journal:  Med (N Y)       Date:  2021-02-23

5.  Pharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma.

Authors:  Eleanor M Pritchard; Elizabeth Stewart; Fangyi Zhu; Cori Bradley; Lyra Griffiths; Lei Yang; Praveen Kumar Suryadevara; Jiakun Zhang; Burgess B Freeman; R Kiplin Guy; Michael A Dyer
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

Review 6.  Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.

Authors:  Santiago Haase; Fernando M Nuñez; Jessica C Gauss; Sarah Thompson; Emily Brumley; Pedro Lowenstein; Maria G Castro
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 7.  Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer.

Authors:  Ariadna Boloix; Marc Masanas; Carlos Jiménez; Roberta Antonelli; Aroa Soriano; Josep Roma; Josep Sánchez de Toledo; Soledad Gallego; Miguel F Segura
Journal:  Front Oncol       Date:  2019-11-06       Impact factor: 6.244

8.  Calcium Signalling in Medulloblastoma: An In Silico Analysis of the Expression of Calcium Regulating Genes in Patient Samples.

Authors:  Ahmed Maklad; Mohammed Sedeeq; Michael J G Milevskiy; Iman Azimi
Journal:  Genes (Basel)       Date:  2021-08-27       Impact factor: 4.096

9.  Loss of KMT2C reprograms the epigenomic landscape in hPSCs resulting in NODAL overexpression and a failure of hemogenic endothelium specification.

Authors:  Shailendra Maurya; Wei Yang; Minori Tamai; Qiang Zhang; Petra Erdmann-Gilmore; Amelia Bystry; Fernanda Martins Rodrigues; Mark C Valentine; Wing H Wong; Reid Townsend; Todd E Druley
Journal:  Epigenetics       Date:  2021-07-24       Impact factor: 4.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.